Report urges companies to hunt for more value from their patents
PatSnap’s “State of IP” report reveals intelligence about patent value, monetisation strategies, IP department budgets and more
PatSnap’s “State of IP” report reveals intelligence about patent value, monetisation strategies, IP department budgets and more
Brian Tenner sits down with IAM to discuss the company’s win and future strategy
GW’s recent ANDA lawsuit is a landmark moment, but will remain untypical of cannabis IP litigation
Life sciences companies are among those leading the way in going to court to get the current rules struck down
20 August 2021
Life sciences innovators may be compelled to hand over trade secrets, data and biological materials under legislation that now only requires President Bolsonaro’s signature to become law
19 August 2021
Companies can take steps to reduce the chance that they’re targeted with a low-quality patent
19 August 2021
Boom in digital healthcare and bioinformatics IP requires strategic adjustments in both the life sciences and high-tech arenas
17 August 2021
The Federal Circuit hands down its second ruling in the carvedilol dispute between Teva and GSK, following widespread concern over its first
13 August 2021
Dow and Johnson Matthey welcome enforcement action, which comes on the heels of a civil trade secrets litigation win in a different Chinese court last year
12 August 2021
There are a lot of potential benefits to the new system, but we need to integrate it into our strategies to make sure it works, explains Joerg Thomaier
11 August 2021
There is now momentum behind several proposed pieces of legislation with implications for life sciences patents
06 August 2021
Poached customers and trade secret worries underpin CATL’s patent suits against a domestic Chinese competitor
06 August 2021
The company is hoping to raise cash to help expand its purchasing power when acquiring pharmaceuticals revenue streams
05 August 2021
Unlock unlimited access to all IAM content